Literature DB >> 25564558

Long-term maternal atherosclerotic morbidity in women with pre-eclampsia.

Roy Kessous1, Ilana Shoham-Vardi2, Gali Pariente1, Ruslan Sergienko2, Eyal Sheiner1.   

Abstract

OBJECTIVE: To investigate whether severe and recurrent pre-eclampsia increase the risk for long-term maternal atherosclerotic disease. STUDY
DESIGN: A population-based study compared the incidence of long-term atherosclerotic morbidity in a cohort of women who delivered in the years 1988-2012. The exposure variable was pre-eclampsia. Mean follow-up duration was 11.2 years. Kaplan-Meier survival curves were used to estimate cumulative incidence of simple, complex (ie, angina pectoris and congestive heart failure, respectively) cardiovascular-related and renal-related hospitalisations. Cox proportional hazards models were used to estimate the adjusted HRs for cardiovascular and renal morbidity.
RESULTS: During the study, 96 370 patients met the inclusion criteria; 7824 (8.1%) in patients who were diagnosed at least once with pre-eclampsia. Patients with pre-eclampsia had higher rates of cardiovascular morbidity including cardiac non-invasive (OR 1.4; 95% CI 1.1 to 1.7; p=0.005) and invasive diagnostic procedures (OR 1.7; 95% CI 1.2 to 2.3; p=0.001), simple (OR 1.5; 95% CI 1.2 to 1.8; p=0.001), as well as complex cardiovascular events (OR 2.4; 95% CI 2.2 to 2.8; p=0.001) and renal (OR 3.7; 95% CI 2.2 to 6.0; p=0.001) hospitalisations. A significant linear association was noted between the severity of pre-eclampsia (no pre-eclampsia, mild pre-eclampsia, severe pre-eclampsia and eclampsia) and cardiovascular (2.7% vs 4.5% vs 5.2% vs 5.7%, respectively; p=0.001), as well as renal disease (0.1% vs 0.2% vs 0.5% vs 1.1%, respectively; p=0.001). Likewise, a linear association was found between the number of previous pregnancies with pre-eclampsia (no pre-eclampsia, one event and ≥2 events of pre-eclampsia) and risk for future simple cardiovascular disease (1.2% vs 1.6% vs 2.2%, respectively; p=0.001), complex cardiovascular disease (1.3% vs 2.7% vs 4.6%, respectively; p=0.001) and total cardiovascular hospitalisations (2.7% vs 4.4% vs 6.0%, respectively; p=0.001). Using a Kaplan-Meier survival curve, patients with pre-eclampsia had significantly higher cumulative incidence of atherosclerotic-related hospitalisations. In a Cox proportional hazards model, adjusted for confounders such as maternal age, parity, diabetes mellitus and obesity, pre-eclampsia remained independently associated with atherosclerotic hospitalisations.
CONCLUSIONS: Previous pregnancy with pre-eclampsia is an independent risk factor for long-term maternal atherosclerotic morbidity. The risk is more substantial for patients with severe and recurrent episodes of pre-eclampsia. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2015        PMID: 25564558     DOI: 10.1136/heartjnl-2014-306571

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring.

Authors:  Eliel Kedar Sade; Tamar Wainstock; Erez Tsumi; Eyal Sheiner
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 2.  Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation.

Authors:  Angélica Lemos Debs Diniz; Maria Marta Bini Martins Paes; Aline Debs Diniz
Journal:  Curr Atheroscler Rep       Date:  2020-02-19       Impact factor: 5.113

Review 3.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

4.  Maternal serum uric acid concentration is associated with the expression of tumour necrosis factor-α and intercellular adhesion molecule-1 in patients with preeclampsia.

Authors:  J Zhao; D-Y Zheng; J-M Yang; M Wang; X-T Zhang; L Sun; X-G Yun
Journal:  J Hum Hypertens       Date:  2015-10-29       Impact factor: 3.012

5.  Caring for Women After Hypertensive Pregnancies and Beyond: Implementation and Integration of a Postpartum Transition Clinic.

Authors:  Ann C Celi; Ellen W Seely; Penny Wang; Ann M Thomas; Louise E Wilkins-Haug
Journal:  Matern Child Health J       Date:  2019-11

Review 6.  What a paediatric nephrologist should know about preeclampsia and why it matters.

Authors:  Giorgina Barbara Piccoli; Massimo Torreggiani; Romain Crochette; Gianfranca Cabiddu; Bianca Masturzo; Rossella Attini; Elisabetta Versino
Journal:  Pediatr Nephrol       Date:  2021-11-04       Impact factor: 3.651

Review 7.  The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.

Authors:  Priya M Freaney; Sadiya S Khan; Donald M Lloyd-Jones; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2020-07-16       Impact factor: 5.113

Review 8.  Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis.

Authors:  Zengfang Wang; Zengyan Wang; Luang Wang; Mingyue Qiu; Yangang Wang; Xu Hou; Zhong Guo; Bin Wang
Journal:  Endocrine       Date:  2016-08-12       Impact factor: 3.633

9.  Increased Cardiac Arrhythmia After Pregnancy-Induced Hypertension: A South Korean Nationwide Database Study.

Authors:  Yoonjee Park; Geum Joon Cho; Seung-Young Roh; Jin Oh Na; Min-Jeong Oh
Journal:  J Am Heart Assoc       Date:  2022-01-11       Impact factor: 6.106

Review 10.  A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics).

Authors:  Liona C Poon; Laura A Magee; Stefan Verlohren; Andrew Shennan; Peter von Dadelszen; Eyal Sheiner; Eran Hadar; Gerard Visser; Fabricio Da Silva Costa; Anil Kapur; Fionnuala McAuliffe; Amala Nazareth; Muna Tahlak; Anne B Kihara; Hema Divakar; H David McIntyre; Vincenzo Berghella; Huixia Yang; Roberto Romero; Kypros H Nicolaides; Nir Melamed; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-07       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.